EyePoint Inc (EYPT)

Currency in USD
3.170
+0.020(+0.63%)
Closed·
3.1700.000(0.00%)
·

EYPT Earnings

Latest Release
Aug 05, 2026
EPS / Forecast
-1.09 / -0.94
Revenue / Forecast
507K / 383K
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
2026/09--/-0.906--/232.15K----Free Sign Up
2026/06-1.09/-0.940507.00K/383.00K-15.96%+32.38%Free Sign Up
2026/03-0.990/-0.820696.00K/1.01M-20.73%-31.09%Free Sign Up
2025/12-0.810/-0.750620.00K/1.05M-8%-40.95%Free Sign Up
2025/09-0.850/-0.770966.00K/3.46M-10.39%-72.08%Free Sign Up
2025/06-0.850/-0.8105.33M/6.66M-4.94%-19.97%Free Sign Up
2025/03-0.650/-0.67024.50M/7.87M+2.99%+211.31%Free Sign Up
2024/12-0.640/-0.50011.58M/10.61M-28%+9.14%Free Sign Up
2024/09-0.540/-0.56010.50M/10.06M+3.57%+4.37%Free Sign Up
2024/06-0.580/-0.5409.48M/9.64M-7.41%-1.66%Free Sign Up

All numbers in USD

EyePoint Inc Earnings Call Summary for Q1/2026

  • EyePoint missed Q1 2026 forecasts with EPS of -$0.99 vs. -$0.82 expected; revenue fell 97.1% YoY to $0.7M as deferred revenue recognition ended.
  • Operating expenses rose 20.5% to $88M driven by Phase III trials for DURAVYU; net loss widened to $85M from $45M in Q1 2025.
  • Company maintains $223M cash position expected to fund operations through Q4 2027 without additional financing needs.
  • DURAVYU Phase III wet AMD data expected mid-2026; DME trial enrollment to complete Q3 2026 as company pursues first-in-class treatment status.
  • Stock rose 2.28% to $14.064 despite earnings miss, reflecting investor optimism about clinical pipeline despite high cash burn and regulatory risks.
Last Updated: 2026-05-06, 09:52 a/m
Read Full Transcript

FAQ

What Is EyePoint's Earnings Per Share (TTM)?

The EyePoint EPS (TTM) is -3.764.

When Is The Next EyePoint Earnings Date?

EyePoint will release its next earnings report on Nov 04, 2026.

What Is EyePoint’s Revenue Forecasts For Upcoming Quarters?

EyePoint’s revenue forecast is 232.15K.

How Did EyePoint React to the Company's Latest Earnings Report?

EyePoint reported a -15.96% EPS surprise and a +32.38% revenue surprise, comparing the latest report against analyst forecasts. The stock price changed by 9.940%, reflecting the market's response to the earnings results.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.